Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling

Introduction: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is implicated in the pathogenesis and progression of autoimmune disease. Patients with rheumatoid arthritis (RA) are at high risk of developing atrial fibrillation (AF), while whether PCSK9 is involved in the onset of AF among RA pa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xuejie Han, Yunlong Gao, Meijiao He, Yingchun Luo, Ying Wei, Yu Duan, Song Zhang, Hui Yu, Jiuxu Kan, Te Hou, Yun Zhang, Yue Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-07-01
Col·lecció:	Journal of Advanced Research
Matèries:	Rheumatoid arthritis Atrial fibrillation PCSK9 Evolocumab
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2090123223002564
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!